Skip to main content
. 2021 Mar 24;2(5):100165. doi: 10.1016/j.jtocrr.2021.100165

Figure 4.

Figure 4

Prognostic factors for OS over a 2-year follow-up period in (A) Swedish and (B) Danish patients diagnosed with locally advanced or metastatic NSCLC at diagnosis (stage IIIB–IV). CI, confidence interval; HR, hazard ratio; NSQ, nonsquamous; OS, overall survival; SQ, squamous.